Bowhead Specialty (BOW) Competitors

Bowhead Specialty (NYSE:BOW) and Oscar Health (NYSE:OSCR) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

Which has more risk and volatility, BOW or OSCR?

Bowhead Specialty has a beta of -0.69, indicating that its stock price is 169% less volatile than the S&P 500. Comparatively, Oscar Health has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500.

Does the media refer more to BOW or OSCR?

In the previous week, Oscar Health had 7 more articles in the media than Bowhead Specialty. MarketBeat recorded 18 mentions for Oscar Health and 11 mentions for Bowhead Specialty. Bowhead Specialty's average media sentiment score of 0.60 beat Oscar Health's score of 0.45 indicating that Bowhead Specialty is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bowhead Specialty	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Oscar Health	5 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	6 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger earnings & valuation, BOW or OSCR?

Bowhead Specialty has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bowhead Specialty	$425.66M	2.43	$38.24M	$1.47	21.43
Oscar Health	$9.18B	0.41	$25.43M	-$0.81	-18.42

Is BOW or OSCR more profitable?

Bowhead Specialty has a net margin of 10.05% compared to Oscar Health's net margin of -1.50%. Bowhead Specialty's return on equity of 13.25% beat Oscar Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bowhead Specialty	10.05%	13.25%	2.94%
Oscar Health	-1.50%	-13.78%	-2.99%

Do institutionals & insiders hold more shares of BOW or OSCR?

75.7% of Oscar Health shares are owned by institutional investors. 25.1% of Oscar Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Do analysts rate BOW or OSCR?

Bowhead Specialty presently has a consensus price target of $39.17, suggesting a potential upside of 24.34%. Oscar Health has a consensus price target of $12.21, suggesting a potential downside of 18.13%. Given Bowhead Specialty's stronger consensus rating and higher probable upside, research analysts clearly believe Bowhead Specialty is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bowhead Specialty	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Oscar Health	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Summary

Bowhead Specialty beats Oscar Health on 11 of the 16 factors compared between the two stocks.